Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Urinary Tract Infections PWM OLLY INDRAJANI 2013 Prevalence of UTIs • Urinary Tract Infection (UTI) is the most common bacterial infection affecting humans • UTI is a serious health problem affecting millions of people each year • Over 8 million Americans seek medical attention for urinary tract infections annually. • Women are especially susceptible: one in five women will have at least one urinary tract infection during her life. Pathophysiology • The urinary system consists of the kidneys, ureters, bladder, and urethra. • The kidneys remove liquid waste from the blood in the form of urine • Keep a stable balance of salts & substances in the blood, and produce a hormone that aids the formation of RBCs. Pathophysiology: continued • The ureters carry urine from the kidneys to the bladder located in the lower abdomen. • Urine is stored in the bladder and emptied through the urethra. • The ureters and bladder normally prevent urine from backing up toward the kidneys, and the flow of urine from the bladder helps wash bacteria out of the body • Normal urine is sterile. • It contains fluids, salts, and waste products. • It is free of bacteria, viruses, and fungi. Pathophysiology: Routes of Infection • Three well recognized routes of infection: • Ascending Transurethral Infection: fecal microorganisms colonizing the periurethral area and enter the bladder via the urethra • Hematogenous: spread as in staphylococcal bacteremia or renal cortex resulting in abscess formation • Direct Extension: enterovesical fistula Pathophysiology: Ascending Transurethral Infection • Is most common route • Short female urethra allows bacteria quick access to the bladder. • Sexual intercourse forces bacteria into bladder • Presence of foreskin, fecal incontinence, and poor toilet habits promote colonization by the fecal bacteria and contribute to the higher prevalence of infection seen in uncircumcised infants, young sexually active men and elderly men with poor anal sphincter control Pathophysiology: Hematogenous Spread • Hematogenous spread of bacteria, fungi, and mycobacteria from distant focus of infection may invade the kidney, bladder or prostate Pathophysiology: Direct Extension • Direct extension of bacteria from the gut into the bladder may occur via a COLOVESICAL, RECTOVESICAL fistula secondary to diverticulitis or colon cancer, Crohn’s disease Classification of Urinary Tract Infections • Lower UTI: cystitis, urethritis, prostatitis • Upper UTI: acute or chronic pyelonephritis, renal or perirenal abscess • Uncomplicated and Complicated lower or upper UTI Classification of Urinary Tract Infections Complicated Lower or Upper UTI: – Risk of renal damage, urosepsis, abscess formation Due to • Presence of functional or anatomic abnormalities, obstruction, calculi/catheter/stent, pregnancy, hospitalization, immunosuppression, diabetes mellitus, sickle cell disease, analgesic/NSAID abuse Classification of Urinary Tract Infections • Acute urethral syndrome: dysuria/frequency with less than 105 colonies/ml of urine • Asymptomatic bacteriuria: asymptomatic with more than 105 colonies of the same bacteria per ml of clean-catch mid-stream urine Presenting Signs & Symptoms Uncomplicated lower UTI Acute Bacterial Cystitis: • Dysuria • Frequency • Urgency • Nocturia • Voiding of small urine volumes • Incontinence • Suprapubic or pelvic pain Associated Signs & Symptoms • • • • • Hematuria Foul smelling cloudy urine Men experience a fullness in the rectum Fever Flank tenderness Acute pyelonephritis • Signs & Symptoms: – Flank or low back pain, chills, fever, sweats, nausea, vomiting, headache and malaise • Associated Signs & Symptoms: – May have symptoms of cystitis – Hematuria, dysuria, polyuria Signs & Symptoms in the Elderly • • • • Less obvious signs: Loss of appetite or a change in eating habits. The sudden onset of confusion Urinary incontinence Complicated UTI: S/S • Clinical manifestations can range from asymptomatic bacteriuria to a severe gram-negative sepsis with shock • Can also present with signs and symptoms of acute cystitis or acute pyelonephritis • Hospitalized patients who suddenly develop signs and symptoms of septic shock or urosepsis should be considered even in the absence of urinary symptoms, particularly after a recent instrumentation of catherization. Physical Findings • Acute Cystitis: – Suprapubic tenderness and distension • Acute Pyelonephritis: – Fever 104 F – Abdominal distension, hypotonic bowel sounds, severe tenderness in lumbar region Physical Examination • PE in men should include: • Inspection and palpation of the genitals for evidence of urethral discharge, meatal erythema, inflammation of the glans penis, penile lesions, enlarged or tender epididymis or testicle, and inguinal lymphadenopathy. • A rectal examination with palpation of the prostate gland should be a standard part of the PE in all men with UTI symptoms Diagnostic studies: • Urinalysis "clean catch“ (midstream) • Urine Culture & Sensitivity • When an infection does not clear up with treatment and is traced to the same strain of bacteria further tests may be ordered: • Computed Tomography (CT) • Ultrasound • Intravenous Pyelogram (IVP) • Cystoscope Diagnostics • Urinalysis test: urine is examined for white and red blood cells and bacteria. • Urine Culture & Sensitivity: bacteria are grown in a culture and tested against different antibiotics to see which drug best destroys the bacteria. • Some microbes, like Chlamydia and Mycoplasma, can be detected only with special bacterial cultures. • One of these infections are suspected when there are symptoms of a UTI and pus in the urine, but a standard culture fails to grow any bacteria. Differential Diagnosis • Acute Bacterial Cystitis should be differentiated from vulvovaginitis caused by yeast, trichomoniasis species or bacterial infections • STDs involving the urethra and cervix such as those caused by C. trachomatis, N. Gonorrhoeae and herpes simplex virus. • Between 10% to 30% of women with STDs or other forms of vaginitis have frequency and dysuria Clinical Decision Making: Differential Diagnosis Vulvovaginitis: external dysuria, soreness of the vulva, malodorous vaginal discharge, pruritus and dyspareunia • Pyuria and hematuria is rare • Urine culture reveals less than 10/2 colonies/ml Urethritis: caused by sexually transmitted pathogensgradual onset of dysuria without other urinary symptoms, vaginal discharge or bleeding or lower abdominal pain. • Pyuria with urine culture showing less than 10/2 colonies/ml • No hematuria Clinical Decision Making based on Laboratory Findings • Urine Dip Stick: – bacterial counts >10/5 Enterobacteriaceae/ml of urine with concomitant pyuria can be detected by this method • Microscopic examination of centrifuged urine can detect the presence of: significant pyuria (>4 WBCs per high power field), hematuria (>4 RBCs per high-power field) or both. • This provides further support for the diagnosis of UTI Clinical Decision Making based on Laboratory Findings • Leukocyte casts: strongly support the diagnosis of pyelonephritis • Urine culture: identifies pathogenic microorganism • 1st a.m. Urine: presence of >1 bacterium per high-power field on a gram-stained film of uncentrifuged urine correlates with >10/5 bacterial colonies/ml in 90% of pts Clinical Decision Making: Differential Diagnosis • Presence of pyuria does not differentiate upper from lower UTIs • Pyuria in the absence of bacteriuria should raise the possibility of renal tuberculosis or allergic interstitial nephritis • Postmenopausal Women: atrophic changes in mucosa of the vulvovagina and urethra caused by hormone deficiency may result in persistent or recurrent frequency and dysuria • Renal and genitourinary neoplasms need to be ruled out Differential Diagnosis • Acute Pyelonephritis – Young female patient should be differentiated from: – Pelvic inflammatory disease – Appendicitis – Atopic pregnancy – Ruptured ovarian cyst Etiology: Risk Factors • Any abnormality of the urinary tract that obstructs the flow of urine such as a kidney stone, sets the stage for an infection. • An enlarged prostate gland can slow the flow of urine - raising the risk of infection • A common source of infection is catheters, or tubes, placed in the bladder. • The elderly or those with nervous system disorders who lose bladder control, may need a catheter for life Etiology: Risk Factors • People with diabetes have a higher risk of a UTI because of changes in the immune system. • Immunosuppressed patients are at risk of a urinary infection. • For many women, sexual intercourse seems to trigger an infection • Women who use a diaphragm are more likely to develop a UTI than women who use other forms of birth control. • Women whose partners use a condom with spermicidal foam also tend to have growth of E. coli bacteria in the vagina Recurrent UTI infections • Nearly 20% of women who have a UTI will have another • 30% of those will have yet another. • Of the last group, 80 percent will have recurrences. • Usually, the latest infection stems from a strain or type of bacteria that is different from the infection before it, indicating a separate infection. • Even when several UTIs in a row are due to E. coli, slight differences in the bacteria indicate distinct infections. Uncomplicated UTIs Organisms Commonly Antibacterial of Found: Choice: Escherichia coli TMP-SMZ or 1st generation cephalosporin Proteus mirabilis Amoxicillin or TMPSMZ Klebsiella pneumoniae TMP-SMZ or 1st generation cephalosporin Enterococcus faecalis Amoxicillin Staphylococcus saprophyticus TMP-SMZ or 1st generation cephalosporin Complicated UTIs E-coli, Proteus & Klebsiella 1st, 2nd, or 3rd generation cephalosporin Enterococcus faecalis Ampicillin or vancomycin + aminoglycoside Pseudomonas Antipseudomonal penicillin + aminoglycoside; ceftazidime; fluoroquinolone Enterobacter Fluoroquinolone; TMPSMZ; Imipenem Indole-+ Proteus & Serratia Acinetobacter 3rd generation cephalosporin; TMP-SMZ Staphylococcus Penicillinase-resistant penicillin or vancomycin Imipenem; TMP-SMZ Clinical Decision Making: Upper vs. Lower UTI • Clinical signs and symptoms may not always be accurate for distinguishing between Upper and Lower UTIs • Distinction between them is best assessed by the response to treatment Clinical Decision Making: • UTIs are treated with antibacterial drugs. • The choice of drug and length of treatment depend on the patient's history and the urine tests that identify the offending bacteria. • The sensitivity test is especially useful in helping to select the most effective drug. Acute Uncomplicated Cystitis: Single Dose Treatment Young woman, first episode •TMP-SMZ Single Dose 320/1600 mg, 2 double strength tabs •Amoxicillin 3gm •Cephaloridine 2gm •Gentamicin 5 mg/kg •Doxycycline 300 mg Acute Uncomplicated Cystitis: Short Course Treatment Young woman, •Trimethoprim 100-200mg q 12 hrs first episode •TMP-SMZ 160/800 mg q 12 hrs •Nitrofurantoin 100 mg q 8 or 6 hrs •Amoxicillin 250 mg q 8 hrs •Ciprofloxacin 250-500 mg q 12 hrs •Norfloxacin 400 mg q 12 hrs Short course 3 to 5 days Acute Uncomplicated Cystitis: •Diabetes Mellitus •Symptoms >7 days •Age >65 yrs •Diaphragm •Trimethoprim 100-200mg q 12 hrs •TMP-SMZ 160/800 mg q 12 hrs •Nitrofurantoin 100 mg q 8 or 6 hrs •Amoxicillin 250 mg q 8 hrs •Ciprofloxacin 250-500 mg q 12 hrs •Norfloxacin 400 mg q 12 hrs 7 to 10 days Acute Uncomplicated Cystitis Young healthy •Trimethoprim 100-200mg q 12 hrs man •TMP-SMZ 160/800 mg q 12 hrs •Ciprofloxacin 250-500 mg q 12 hrs •Norfloxacin 400 mg q 12 hrs 7 to 10 days Recurrent Cystitis •TX based on sensitivity results •R/O renal stones, Scars, cysts, Chronic Bacterial Prostatitis 14 days <2 episodes/yr TX as 1st episode in young woman Single dose or 3-5 days >3 episodes/yr TMP+SMZ, amoxicillin, Nitrofurantoin, ciprofloxacin or Norfloxacin, followed by lowdose antibiotic prophylaxis 3-5 days, then 1 yr of prophylaxis Relapses Reinfection: Recurrent Cystitis Temporally related to coitus Postmenopause TMP+SMZ, Postcoital Nitrofurantoin prophylaxis cephalexin; voiding after intercourse Topical estradiol cream+lowdose antibiotic prophylaxis Asymptomatic Bacteriuria With/without catheter No TX unless Pregnancy Amoxicillin/Ampicillin, Nitrofurantoin oral cephalosporin 10 – 14 days symptomatic, neutropenic, renal transplant, urea splitting bacteria, obstruction, diabetes mellitus, sickle cell disease/trait, NSAID/analgesic abuse 3 – 5 days Acute Uncomplicated Pyelonephritis Very sick or septic Parenteral: TMP-SMZ, ciprofloxacin, ceftriaxone, or gentamicin+ampicillin until afebrile, then oral regimen 14 days; if relapse, 6 weeks Not very sick Oral: TMP+SMZ, amoxicillin, ciprofloxacin, Norfloxacin 14 days; if relapse, 6 weeks Pregnancy Parenteral: ceftriaxone, gentamicin+ampicillin , aztreonam, or TMPSMZ until afebrile, then oral regimen 14 days Symptomatic Complicated Upper UTI Very sick or septic Parenteral: gentamicin+ampicilli n, ceftriaxone, aztreonam, imipenem-cilastatin, ciprofloxacin, ticarcillinclavulanate 2 – 3 week; if relapse, 6 weeks Not very sick Oral: ciprofloxacin, Norfloxacin, or TMP-SMZ (if sensitive) 2 – 3 week; if relapse, 6 weeks Patient Education • Teach proper hygiene: Women wipe from front to back to prevent bacteria around the anus from entering the vagina or urethra. • Take showers instead of tub baths • Encourage patient to increase fluid intake and avoid of bladder irritants such as caffeine, smoking and alcohol. • Recommend cranberry juice that may decrease bladder colonization • Encourage patient to urinate when he/she feels the need Patient Education: Continue • Advise voiding before and after sex • Cleanse the genital area before and after sexual intercourse. • Recommend alternative methods of contraception for women using diaphragms if recurrent infections exist • Avoid using feminine hygiene sprays and scented douches, which may irritate the urethra. • Discuss the need to complete entire course of medication Follow-up & Referrals Follow-up: • Repeat U/C after completion of medication • Advise pt to return if s/s increase in severity or fail to improve after 3 days of therapy. Consultation/Referral if: • Renal Calculi are suspected • Infection persists after two courses of appropriate treatment • If pyelonephritis is suspected • If patient has insulin dependent diabetes • When patient has existing renal disease • History of 3 UTIs in one year